Professor Scott Bell is the Chief Executive of the Translational Research Institute and a Senior Physician of the Adult Cystic Fibrosis Centre at The Prince Charles Hospital where he has worked since 1996 in Brisbane. He was Director between 1996-2015. As a clinician scientist, he leads the Lung Bacteria Laboratory at UQ. Scott has >300 peer-reviewed publications and has received grant support >$24 million. His research interests include acquisition and transmission pathways for human infection and his multi-disciplinary research has resulted in significant changes to clinical practice and policy implementation globally. He has been the principal investigator on numerous pivotal CFTR modulator trials. He was the Editor of the Journal of Cystic Fibrosis from 2013 until 2020 and co-led the Lancet Commission on the future of CF care which was published in 2020.

Prof Josephine Forbes is a translational researcher performing bench to bedside studies on novel therapies to prevent type 1 diabetes and a major complication, kidney disease. Currently she based at Mater Research - The University of Queensland in Australia. Josephine is the Australian Diabetes Society President-Elect, the previous chair of the Diabetes Australia Research Program and an editor board member for journals including Kidney International and Diabetologia. She is also continually in the top 2% of scientists globally as published annually by Stanford University, with an H index of 64. Josephine has published ~200 research articles with >15000 citations and three patents. She has received numerous prizes for her research including the Commonwealth Health Minister’s Award for Excellence in Health and Medical Research in Australia.

Dr. Taylor heads the Respiratory Health Group within the Microbiome and Host Health Programme at SAHMRI.